Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
2013 Science
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory
2006
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs
2015
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2008
Advances in mass spectrometry-based clinical biomarker discovery
2016
Breast cancer
2019 Standout
Treatment of kidney cancer
2009 StandoutNobel
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2012
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?
2007
WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
2013
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Netting neutrophils in autoimmune small-vessel vasculitis
2009 Standout
Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation
2006
Gender medicine and oncology: report and consensus of an ESMO workshop
2019
Breast cancer
2016 Standout
Implementing the reuse of public DIA proteomics datasets: from the PRIDE database to Expression Atlas
2022
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
2021
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy
2018
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Oral Anticoagulant Therapy
2012 Standout
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
2007
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity
2008
Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas
2010
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force
2015
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
2012
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
2012
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysis
2015
MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer
2016
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Colorectal cancer
2019 Standout
Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
2007
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
2003 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Circulating Nucleic Acids in Plasma and Serum
2008
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
2010
Drug repurposing: progress, challenges and recommendations
2018 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
Nucleosomal DNA Fragments in Autoimmune Diseases
2006
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Analysis of anticancer drugs: A review
2011 Standout
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
2013
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Gemcitabine-associated thrombotic thrombocytopenic purpura
2007
Advancing translational research and precision medicine with targeted proteomics
2018
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients
2010
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis
2012
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
2010
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
2022
Circulating nucleic acids (CNAs) and cancer—A survey
2006
The PI3K Pathway in Human Disease
2017 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches
2016
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
2010
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
Is therapeutic plasma exchange indicated for patients with gemcitabine‐induced hemolytic uremic syndrome?
2009
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases
2016
LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength
2016 StandoutNobel
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
2015
Slaying RAS with a synthetic lethal weapon
2010 StandoutNobel
Plasma cell‐free DNA in ovarian cancer
2010
Pheochromocytoma: presentation, diagnosis and treatment
2006
Research into cancer metabolomics: Towards a clinical metamorphosis
2015
Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin
2005
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients
2013
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)
2007
Adapting Data-Independent Acquisition for Mass Spectrometry-Based Protein Site-Specific N-Glycosylation Analysis
2017
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
2019
Obesity and Cancer Mechanisms: Cancer Metabolism
2016
Structure of the human volume regulated anion channel
2018 StandoutNobel
Fundamentals of cancer metabolism
2016 Standout
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
2021 Standout
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
2016 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
2008
Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients
2012
Gemcitabine‐induced thrombotic microangiopathy
2013
Computerized advice on drug dosage to improve prescribing practice
2008
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
2007
Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer
2007
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
2005
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials
2015
Anti-Angiogenic Therapy in Uveal Melanoma
2011
Works of Markus Joerger being referenced
Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy
2015
Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?
2010
Chemotherapy regimens in early breast cancer: major controversies and future outlook
2013
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate
2006
Treatment of breast cancer in the elderly: A prospective, population-based Swiss study
2012
Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
2012
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
2015
Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
2015
Antiangiogenic Drugs in Oncology: A Focus on Drug Safety and the Elderly – A Mini-Review
2009
Von Hippel-Lindau Disease – a Rare Disease Important to Recognize
2005
Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring
2012
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
2012
Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients
2005
Gemcitabine-associated hemolytic-uremic syndrome
2002
Therapeutic drug monitoring of non-anticancer drugs in cancerpatients
2004
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
2005
Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry
2005
Predictors of state-of-the-art management of early breast cancer in Switzerland
2010
Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma
2014
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers
2006
Management and Costs of Treating Lung Cancer Patients in a University Hospital
2004
Update of the BIG 1–98 Trial: Where do we stand?
2009
A phase 1 first-in-human (FIH) dose-escalation (DE) study of the oral dual PI3K/mTOR inhibitor PQR309 in patients (pts) with advanced solid tumors: Final DE results.
2015
Phase lb study of BEZ235 plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC).
2014
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy
2018
Cancer chemotherapy: targeting folic acid synthesis
2010
Quantitative Effect of Gender, Age, Liver Function, and Body Size on the Population Pharmacokinetics of Paclitaxel in Patients with Solid Tumors
2006
Cancer chemotherapy: targeting folic acid synthesis.
2010
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
2004
Preliminary results of a phase I/IIa study of BMS-986156 (glucocorticoid-induced tumor necrosis factor receptor–related gene [GITR] agonist), alone and in combination with nivolumab in pts with advanced solid tumors.
2017
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors
2019
Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer
2009